OM (Outset Medical) Tariff Resilience Score: 6/10 (As of Aug. 07, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

OM Outset Medical Inc OM
64 GF Score
Price $4.74
GF Value $4.18
Valuation Modestly Overvalued
! 3 Warning Signs
View Full Analysis

What is Outset Medical Tariff Resilience Score?

Outset Medical OM -8.51% 64 Tariff Resilience Score is 6 as of Aug. 07, 2026. GuruFocus rates OM with a GF Score™ of 64/100 and a GF Value™ of $4.18 (Modestly Overvalued). The stock has 3 warning signs investors should review. Among 829 Medical Devices & Instruments companies, Outset Medical ranks better than 90.95% on this metric.

Outset Medical has the Tariff Resilience Score of 6, which implies that the company might have Average Resilient.

Outset Medical has Outset Medical relies on a global supply chain for components, but its primary market is domestic. The company has some flexibility with suppliers and moderate pricing power, reducing tariff impact. Historical tariff changes have had limited impact on its operations.

Tariff Resilience Score is a ranking system developed by GuruFocus to measure a company's exposure to international trade tariffs, rated on a scale from 0 to 10. It takes into account key factors such as global supply chain dependencies, manufacturing locations versus sales markets, import / export balance and percentage of revenue, and more.

The company's exposure to international trade tariffs based on these criteria:

1. Global supply chain dependencies
2. Manufacturing locations versus sales markets
3. Import/export balance and percentage of revenue
4. Historical impact from previous tariff changes
5. Available mitigation strategies (alternative suppliers, pricing power)
6. Industry-specific tariff exemptions or vulnerabilities

Based on the research, GuruFocus believes Outset Medical might have Average Resilient.

Outset Medical  (NAS:OM) Tariff Resilience Score Explanation

The Tariff Resilience Score ranges from 0 to 10, with 10 as the most resilient. GuruFocus divided Moat Score into following 3 categories:

Tariff Resilience Score Resilience Level
7 - 10Highly Resilient
4 - 6Average Resilient
0 - 3Highly Vulnerable

Outset Medical Tariff Resilience Score Related Terms

OM vs SERA, LNSR, ZOMDF: Tariff Resilience Score Comparison

For the Medical Devices subindustry, Outset Medical's Tariff Resilience Score, along with its competitors' market caps and Tariff Resilience Score data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Outset Medical Tariff Resilience Score vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Outset Medical's Tariff Resilience Score distribution charts can be found below:

* The bar in red indicates where Outset Medical's Tariff Resilience Score falls into.


OM
64GF Score
Outset Medical Inc OM
Tariff Resilience Score is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis
What does a Tariff Resilience Score of 6 mean?
Outset Medical (OM) has a Tariff Resilience Score of 6 as of Aug. 07, 2026. Tariff Score is a ranking system developed by GuruFocus to measure a company's exposure to international trade tariffs, rated on a scale from 0 to 10. It takes into account key factors such as global supply chain dependencies, manufacturing locations versus sales markets, import / export balance and percentage of revenue, and more. According to the industry distribution chart, Outset Medical ranks #75 out of 829 companies in the Medical Devices & Instruments industry, placing it in the top 9%.
Is Outset Medical's Tariff Resilience Score too high?
Outset Medical's current Tariff Resilience Score is 6. Based on the distribution chart, Outset Medical ranks #75 out of 829 companies in the Medical Devices & Instruments industry, which is in the top quartile — a strong position relative to peers. Overall, Outset Medical has a GF Score™ of 64/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Outset Medical's Tariff Resilience Score compare to SERA and LNSR?
According to the Medical Devices & Instruments industry distribution chart, Outset Medical ranks #75 out of 829 companies for Tariff Resilience Score. This places Outset Medical in the top 9% of its industry — outperforming the majority of peers. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Tariff Resilience Score for a Medical Devices & Instruments company?
A good Tariff Resilience Score depends on the Medical Devices & Instruments industry context. However, Tariff Resilience Score should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Tariff Resilience Score mean?
A high Tariff Resilience Score can signal that a stock is expensive relative to its fundamentals. Tariff Score is a ranking system developed by GuruFocus to measure a company's exposure to international trade tariffs, rated on a scale from 0 to 10. It takes into account key factors such as global supply chain dependencies, manufacturing locations versus sales markets, import / export balance and percentage of revenue, and more. Outset Medical's current Tariff Resilience Score is 6. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Outset Medical stock overvalued right now?
Based on GuruFocus' analysis, Outset Medical (OM) is currently considered Modestly Overvalued. The stock's GF Value™ is $4.18, compared to a current price of $4.74 — trading 13.4% above its estimated fair value. The current Tariff Resilience Score is 6. Outset Medical's overall GF Score™ is 64/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Tariff Resilience Score calculated?
Tariff Resilience Score is calculated from a company's financial statements. For Outset Medical (OM), the current Tariff Resilience Score is 6 as of Aug. 07, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Outset Medical (OM) Overvalued in 2026?

Based on GuruFocus' analysis, Outset Medical stock appears to be overvalued. The current stock price of $4.74 is trading 13.4% above its estimated GF Value™ of $4.18. GuruFocus considers Outset Medical to be Modestly Overvalued.

Key valuation signals for OM:

  • Tariff Resilience Score: 6
  • GF Value™: $4.18 vs. price of $4.74 (13.4% above fair value)
  • GF Score™: 64/100 with 3 warning signs

No single metric tells the full story. See the OM stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Outset Medical Business Description

Address 3052 Orchard Drive, San Jose, CA, USA, 95134
Outset Medical Inc is a medical technology company pioneering a technology to reduce the cost and complexity of dialysis. The Company generates revenue from the sales of Tablo consoles and related consumables, including Tablo cartridges and accessories.
64GF Score

Get the complete analysis for OM

Tariff Resilience Score is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$4.74
Price
$4.18
GF Value